Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Evelo Biosciences Inc
(NQ:
EVLO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 11, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Evelo Biosciences Inc
Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis
October 17, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights
August 14, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Inc. (NASDAQ: EVLO) Leading the Way in Friday Trading Based on Percentage Gain
July 21, 2023
Via
Investor Brand Network
Exposures
COVID-19
Evelo Biosciences Inc. (NASDAQ: EVLO) Near the Top of Equities by Percentage Gain on 7/18
July 18, 2023
Via
Investor Brand Network
Exposures
COVID-19
Evelo Biosciences Closes $25.5 Million Private Placement
July 12, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Announces $25.5 Million Private Placement
July 10, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Announces Reverse Stock Split Effective
June 29, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Provides Clinical Updates
April 26, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
March 16, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
March 09, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference
March 01, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial
February 27, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Provides Clinical and Business Updates
February 01, 2023
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt
December 16, 2022
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Announces Publication of Scientific Basis for SINTAX Medicines in Frontiers in Immunology
November 15, 2022
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights
November 14, 2022
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Evelo Biosciences to Present at the 2022 Jefferies London Healthcare Conference
November 08, 2022
From
Evelo Biosciences, Inc.
Via
GlobeNewswire
Global Multiple Sclerosis Drugs Market Expected to Reach $41.99 Billion in 2028
February 03, 2022
Palm Beach, FL –– February 3, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system. It is characterized by demyelination,...
Via
FinancialNewsMedia
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.